Sallabanda, M.; Vera, J.A.; Pérez, J.M.; Matute, R.; Montero, M.; de Pablo, A.; Cerrón, F.; Valero, M.; Castro, J.; Mazal, A.;
et al. Five-Fraction Proton Therapy for the Treatment of Skull Base Chordomas and Chondrosarcomas: Early Results of a Prospective Series and Description of a Clinical Trial. Cancers 2023, 15, 5579.
https://doi.org/10.3390/cancers15235579
AMA Style
Sallabanda M, Vera JA, Pérez JM, Matute R, Montero M, de Pablo A, Cerrón F, Valero M, Castro J, Mazal A,
et al. Five-Fraction Proton Therapy for the Treatment of Skull Base Chordomas and Chondrosarcomas: Early Results of a Prospective Series and Description of a Clinical Trial. Cancers. 2023; 15(23):5579.
https://doi.org/10.3390/cancers15235579
Chicago/Turabian Style
Sallabanda, Morena, Juan Antonio Vera, Juan MarÃa Pérez, Raúl Matute, Marta Montero, Ana de Pablo, Fernando Cerrón, Mireia Valero, Juan Castro, Alejandro Mazal,
and et al. 2023. "Five-Fraction Proton Therapy for the Treatment of Skull Base Chordomas and Chondrosarcomas: Early Results of a Prospective Series and Description of a Clinical Trial" Cancers 15, no. 23: 5579.
https://doi.org/10.3390/cancers15235579
APA Style
Sallabanda, M., Vera, J. A., Pérez, J. M., Matute, R., Montero, M., de Pablo, A., Cerrón, F., Valero, M., Castro, J., Mazal, A., & Miralbell, R.
(2023). Five-Fraction Proton Therapy for the Treatment of Skull Base Chordomas and Chondrosarcomas: Early Results of a Prospective Series and Description of a Clinical Trial. Cancers, 15(23), 5579.
https://doi.org/10.3390/cancers15235579
